SCHEMBL10104263

SCHEMBL10104263

CN1C(=O)c2cccc3c(NCCCn4cc[n+](CCSSCC[n+]5ccn(CCCNc6ccc7c8c(cccc68)C(=O)N(C)C7=O)c5)c4)ccc(c23)C1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.48
KMT2A Q03164 6/20 0.48
USP2 O75604 3/20 0.48
POLB P06746 3/20 0.48
ATM Q13315 2/20 0.48
MAPT P10636 2/20 0.48
HTT P42858 2/20 0.48
RGS12 O14924 1/20 0.48
MAPK1 P28482 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
TLR9 Q9NR96 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
KEAP1 Q14145 2/20 0.46
NFE2L2 Q16236 2/20 0.46
DYRK3 O43781 1/20 0.43
RPS6KB1 P23443 1/20 0.43
EPHA2 P29317 1/20 0.43
FLT4 P35916 1/20 0.43
CSNK2A1 P68400 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13207621 0.94 MEN1 (0.48) MEN1KMT2AUSP2POLBATM
SCHEMBL13207571 0.90 KMT2A (0.45) MEN1KMT2AUSP2POLBATM
SCHEMBL13207572 0.90 MEN1 (0.49) MEN1KMT2AUSP2POLBATM
SCHEMBL13207584 0.87 MEN1 (0.47) MEN1KMT2AUSP2POLBATM
SCHEMBL16070400 0.86 MEN1 (0.39) MEN1KMT2AUSP2POLBATM
SCHEMBL13207582 0.85 MEN1 (0.42) MEN1KMT2AUSP2POLBATM
SCHEMBL13207586 0.85 MEN1 (0.42) MEN1KMT2AUSP2POLBATM
SCHEMBL1760735 0.84 MEN1 (0.54) MEN1KMT2AUSP2POLBATM
SCHEMBL13207570 0.84 MEN1 (0.41) MEN1KMT2AUSP2POLBATM
SCHEMBL1760808 0.83 MEN1 (0.52) MEN1KMT2AUSP2POLBATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2004759-B1 METHOD OF DYEING AND LIGHTENING KERATIN MATERIALS IN THE PRESENCE OF A REDUCING AGENT COMPRISING A FLUORESCENT DISULPHIDE DYE ORÉAL L (FR) 2016-05-11 EP disclosed
EP-2018847-B1 Hair composition comprising at least one direct disulfide dye and at least one alkali hydroxide agent and method of simultaneous styling and dyeing. ORÉAL L (FR) 2014-09-17 EP disclosed
US-8097044-B2 Hair compositions comprising at least one disulfide direct dye and at least one alkaline hydroxide agent and simultaneous hair shaping and dyeing processes L'OREAL S.A. (FR) 2012-01-17 US disclosed
US-8038731-B2 hair dyes contains naphthylimide thiol or disulphide groups; resistant and visible lightening effect on dark keratin fibres; cosmetics L'OREAL S.A. (FR) 2011-10-18 US disclosed
US-8038731-B2 hair dyes contains naphthylimide thiol or disulphide groups; resistant and visible lightening effect on dark keratin fibres; cosmetics L'OREAL S.A. (FR) 2011-10-18 US disclosed
US-7780743-B2 Fluorescent entity, dyeing composition containing at least one fluorescent entity, and method for lightening keratin materials using said at least one fluorescent entity L'OREAL S.A. (FR) 2010-08-24 US disclosed
US-20090320216-A1 Fluorescent entity, dyeing composition containing at least one fluorescent entity, and method for lightening keratin materials using said at least one fluorescent entity L'OREAL S.A. (FR) 2009-12-31 US disclosed
US-20090313769-A1 METHOD OF DYEING AND LIGHTENING KERATIN MATERIALS IN THE PRESENCE OF A REDUCING AGENT COMPRISING A FLUORESCENT DISULPHIDE DYE L'OREAL S.A. (FR) 2009-12-24 US disclosed
US-20090313769-A1 METHOD OF DYEING AND LIGHTENING KERATIN MATERIALS IN THE PRESENCE OF A REDUCING AGENT COMPRISING A FLUORESCENT DISULPHIDE DYE L'OREAL S.A. (FR) 2009-12-24 US disclosed
US-20090126755-A1 Hair compositions comprising at least one disulfide direct dye and at least one alkaline hydroxide agent and simultaneous hair shaping an dyeing processes L'OREAL S.A. (FR) 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090126755-A1 Hair compositions comprising at least one disulfide direct dye and at least one alkaline hydroxide agent and simultaneous hair shaping an dyeing processes KRT18, DSG1, ALPG MEN1 3833/4885KMT2A 1006/4885USP2 2451/4885
US-20090320216-A1 Fluorescent entity, dyeing composition containing at least one fluorescent entity, and method for lightening keratin materials using said at least one fluorescent entity KRT18, NAP1L4, NAP1L1 MEN1 3663/4885KMT2A 673/4885USP2 1920/4885
US-20090313769-A1 METHOD OF DYEING AND LIGHTENING KERATIN MATERIALS IN THE PRESENCE OF A REDUCING AGENT COMPRISING A FLUORESCENT DISULPHIDE DYE KRT18, DSG1, KRTCAP2 MEN1 3694/4885KMT2A 1186/4885USP2 1400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.